Liver Disease Clinical Trials

Showing 21-40 of 690 trials

GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery

NCT05900037

This is a pre-market, prospective, randomized (1:1), multicenter, pivotal clinical investigation. The purpose of this investigation is to determine the clinical performance of GATT-Patch as compared with SURGICEL® Original for the management of minimal, mild, or moderate bleeding during minimally invasive liver and gallbladder surgery.

Intraoperative BleedingLiver DiseasesGallbladder Diseases+1 more

GATT Technologies BV53 participantsStarted Oct 2023

Los Angeles, California, United States • St Louis, Missouri, United States • Pennington, New Jersey, United States +3 more locations

RECRUITING

Mechanism of TIPS to Improve Sarcopenia

NCT06794853

Sarcopenia is particularly common in patients with chronic liver disease, especially in patients with decompensated cirrhosis, where the prevalence can be more than 50%. Sarcopenia is an important risk factor for a significant increase in mortality in cirrhotic patients, and is closely associated with a high incidence of complications such as hepatic encephalopathy, ascites, and infections . Recent studies have found that TIPS not only significantly improves clinical symptoms caused by portal hypertension, but may also have a positive effect on skeletal muscle mass and function in patients. Although the effect of TIPS in improving sarcopenia has been preliminarily confirmed, its mechanism is not yet fully understood. Therefore, there is an urgent need to explore the mechanism of action of TIPS to improve sarcopenia and provide guidance for clinical treatment options.

SarcopeniaMechanismCirrhosis

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology132 participantsStarted Jun 2025

Wuhan, Taiwan

GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery

Mechanism of TIPS to Improve Sarcopenia

Related Searches

Effect of Insulin Lowering on Lipogenesis

Impact of Circadian Exercise on Metabolic Dysfunction-Associated Steatotic Liver Disease in Postmenopausal Women

Human Models of Selective Insulin Resistance: Pancreatic Clamp

Team Science (The Liver Health Study)

Using Autologous Bone Marrow Cells With Wharton Gel Exosomes to Stimulate Hepatic Cell Repair in Liver Cirrhosis

Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM

MHT and Liver Function in Postmenopausal Women

Breath Analysis Based Disease Biomarkers

Social & Contextual Impact on Children Undergoing Liver Transplantation

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease

Study of the Link Between MASH ( Metabolic Dysfunction-Associated Steatohepatitis) and MAMs (Mitochondria-Associated Membranes ) Alteration in Patients Undergoing Bariatric Surgery - MAMBA

Diagnosis of Lymphohistiocytic Hemophagocytosis in Intensive Care

Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

Liver Cirrhosis Network Cohort Study

A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD